The Business of Autism: Private Equity, Medicaid & the Cost of Care
About this episode
The episode discusses the growth of Medicaid spending on autism treatment and the role of private equity in the ABA therapy market.
Health Affairs Publishing's Jeff Byers welcomes Dan Arnold of Brown University to discuss the rapid growth of Medicaid spending on autism treatment and the expanding role of private equity-backed providers in the applied behavior analysis (ABA) therapy market. He explores the drivers behind rising costs, emerging concerns about care quality and fraud, and the challenge of balancing oversight with continued access to services for families. Related Links: The Business Of Autism Treatment: Private Equity Implications For State Medicaid Programs ( Health Affairs Forefront ) Sign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.
More episodes of Health Affairs This Week
- The $22 Billion Surprise Inside the No Surprises Act | Jack Hoadley
- Medicare Advantage's $16 Billion Quality Bonus Program: Litigation, Reform, and Rising Costs
- AI and the Future of Patient Empowerment
- When Academic Research Meets The Attention Economy
- BEST OF: Future of Primary Care: Bright or Broken? w/ Troyen Brennan
- Health Research Funding Suddenly Cut: Dr. Aaron Carroll Explains
Explore listener stats, chart rankings, contacts and more on the Health Affairs This Week podcast page.